-
Mashup Score: 2
The FDA told staff on Monday that reviewers of medical products and inspectors of manufacturing facilities cannot take the buyout offer circulated on Friday from HHS that would’ve provided as much as $25,000 in severance, three FDA officials confirmed to Endpoints News.
Source: endpts.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 2
Moderna says its long-running patent dispute with Pfizer and BioNTech isn’t over even after a decision by an administrative tribunal that invalidated two of its Covid-19 vaccine-related patents.
Source: endpts.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 4
Sanofi faces $250M charge after E. coli vaccine developed with J&J fails Phase 3 trial; study ends early due to insufficient efficacy in preventing invasive disease
Source: endpts.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Judge halts some NIH cuts after 22 states sue - 1 month(s) ago
A federal court in Massachusetts temporarily blocked the Trump administration’s new cap on indirect cost reimbursements for NIH grant recipients within the 22 states that are challenging it.
Source: endpts.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0AbbVie wins FDA approval for new antibiotic to treat complex intra-abdominal infections - 1 month(s) ago
The FDA has approved Emblaveo in combination with metronidazole for complicated intra-abdominal infections, providing a new tool to fight antimicrobial resistance.
Source: endpts.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 6
Indian drugmaker Maithili Life Sciences has received a non-compliant report from the Brussels-based Federal Agency for Medicines and Health Products for issues related to APIs.
Source: endpts.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Major FDA staff cuts would slow drug reviews, experts say - 1 month(s) ago
The Trump administration’s reported plans to potentially lay off thousands of FDA employees could slow the agency’s reviews of new drugs, experts say, in addition to impacting other core agency functions.
Source: endpts.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 44
All nine late-stage kidney cancer patients in a Phase 1 trial of a personalized vaccine remained cancer-free after more than three years of receiving treatment, researchers wrote in a Nature paper published on Wednesday.
Source: endpts.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6We’re about to find out which RFK will show up at HHS - 1 month(s) ago
Robert F. Kennedy Jr. advances toward Senate confirmation despite vaccine controversy, as key skeptic Sen. Bill Cassidy backs nomination after receiving
Source: endpts.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 3New study will try to stop Alzheimer’s decades before it begins, using experimental Eli Lilly drug - 1 month(s) ago
Alzheimer’s disease has afflicted Hannah Richardson’s family for generations. A rare genetic mutation, passed down from her great-grandmother, has struck her relatives with the first signs of memory loss at …
Source: endpts.comCategories: General Medicine News, General HCPsTweet
RT @ZacharyBrennan: FDA blocks drug and device reviewers from taking HHS' buyout offer - https://t.co/015tTGnfQ8